✦ LIBER ✦

Adoptive transfer of T-cell immunity

✍ Scribed by Helmut W.H.G Kessels; Monika C Wolkers; Ton N.M Schumacher

Book ID: 117787217
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 45 KB
Volume: 23
Category: Article
ISSN: 1471-4906
DOI: 10.1016/s1471-4906(02)02219-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adoptive transfer of T-cell immunity: ge

Adoptive transfer of T-cell immunity: gene transfer with MHC-restricted receptors

✍ Reno Debets; Ralph Willemsen; Reinder Bolhuis 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Adoptive transfer of T-cell immunity: ge

Adoptive transfer of T-cell immunity: gene transfer with MHC-restricted receptors

✍ Ton N.M Schumacher; Monika C Wolkers; Helmut W.H.G Kessels 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 25 KB

Adoptive transfer of virus-specific and

Adoptive transfer of virus-specific and tumor-specific T cell immunity

✍ Carolina Berger; Cameron J Turtle; Michael C Jensen; Stanley R Riddell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Augmentation of anti-tumor immunity by a

Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation

✍ Bleakley, Marie; Turtle, Cameron J; Riddell, Stanley R 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 936 KB

Restoration of immunity in lymphopenic i

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

✍ Rapoport, Aaron P; Stadtmauer, Edward A; Aqui, Nicole; Badros, Ashraf; Cotte, Ju 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

Adoptive transfer of immunity to hepatit

Adoptive transfer of immunity to hepatitis B virus after T cell–depleted allogeneic bone marrow transplantation

✍ Yaron Ilan; Arnon Nagler; Ruth Adler; Elizabeth Naparstek; Reuven Or; Shimon Sla 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Recipients of allogeneic bone marrow transplantation are pancytopenic for several weeks and immunosuppressed for many months as a result of myeloablative therapy required to eliminate the basic disease and to prevent allograft rejection. After bone marrow transplantation, these patients remain profo